Benzinga's Top Downgrades
February 11, 2015 at 09:08 AM EST
Analysts at Goldman Sachs downgraded Impax Laboratories Inc. (NASDAQ: IPXL) from Buy to Neutral. The price target for Impax Laboratories ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.